Abstract
The COVID-19 pandemic halted longevity improvements and mortality reductions at older ages in 2020. Life expectancy at birth — a widely-used indicator of population health — declined from 2019 to 2020 in 24 out of 26 countries for which high-quality vital statistics are presently available, including most European countries, Chile and the USA. Males in the USA and Bulgaria experienced the largest losses in life expectancy at birth during 2020 (2.1 and 1.6 years respectively), but staggering reductions of more than an entire year were documented in eleven countries for males, and seven among females; a magnitude of loss not witnessed since WW-II in many countries. Reductions were mostly attributable to increased mortality above age 60 and to official COVID-19 deaths.
One-sentence summary COVID-19 erased years of life expectancy gains in several countries, with the biggest losses for US and Bulgarian males.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding is gratefully acknowledged from the British Academy's Newton International Fellowship grant NIFBA19/190679 (JMA, RK), a Rockwool Foundation's Excess Deaths grant (JMA, JS, TIM, IK), a Leverhulme Trust Large Centre Grant (JMA, LZ, RK, CR, JBD and MCM), Nuffield College (JM, RK, CR, JBD, MCM), John Fell Fund grant 0009182 (JMA, RK, CR, JBD, MCM) and European Research Council grant 835079 (MCM).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The replication files for this paper including customised functions in the statistics environment R are available on Zenodo, a general-purpose open-access repository developed under the European OpenAIRE program and operated by CERN (10.5281/zenodo.4556982). We would like to thank Alyson van Raalte, Jim Oeppen, Christiaan Monden and John Ermisch for their insightful comments on the manuscript. We also thank Ainhoa Alustiza for her timely response on issues related to the STMF dataset. Funding is gratefully acknowledged from the British Academy’s Newton International Fellowship grant NIFBA19/190679 (JMA, RK), a Rockwool Foundation’s Excess Deaths grant (JMA, JS, TIM, IK), a Leverhulme Trust Large Centre Grant (JMA, LZ, RK, CR, JBD and MCM), Nuffield College (JM, RK, CR, JBD, MCM), John Fell Fund grant 0009182 (JMA, RK, CR, JBD, MCM) and European Research Council grant 835079 (MCM).
A collaboration between the Interdisciplinary Centre on Population Dynamics, University of Southern Denmark and the Leverhulme Centre for Demographic Science, University of Oxford
Data Availability
The replication files for this paper including customised functions in the statistics environment R are available on Zenodo, a general-purpose open-access repository developed under the European OpenAIRE program and operated by CERN (10.5281/zenodo.4556982).
